VentriPoint Nabs $1.2M

6/20/11

Seattle-based VentriPoint Diagnostics, a company seeking to develop fast, accurate ways to diagnose heart problems, has raised $1.2 million out of a financing round that could be worth as much as $3 million, according to a regulatory filing. The company, led by CEO George Adams, is using ultrasound and MRI instruments to construct 3-D images of the heart, particularly in newborns with congenital heart defects, according to a technology description on the company’s website.

By posting a comment, you agree to our terms and conditions.